A primate-specific endogenous retroviral envelope protein sequesters SFRP2 to regulate human cardiomyocyte development

Ran Zhang,Menghua Wu,Dan Xiang,Jieying Zhu,Qi Zhang,Hui Zhong,Yuling Peng,Zhenhua Wang,Gang Ma,Guihuan Li,Fengping Liu,Weipeng Ye,Ruona Shi,Xuemeng Zhou,Isaac A Babarinde,Huanxing Su,Jiekai Chen,Xiaofei Zhang,Dajiang Qin,Andrew P Hutchins,Duanqing Pei,Dongwei Li
DOI: https://doi.org/10.1016/j.stem.2024.07.006
IF: 23.9
2024-08-06
Cell Stem Cell
Abstract:Endogenous retroviruses (ERVs) occupy a significant part of the human genome, with some encoding proteins that influence the immune system or regulate cell-cell fusion in early extra-embryonic development. However, whether ERV-derived proteins regulate somatic development is unknown. Here, we report a somatic developmental function for the primate-specific ERVH48-1 (SUPYN/Suppressyn). ERVH48-1 encodes a fragment of a viral envelope that is expressed during early embryonic development. Loss of ERVH48-1 led to impaired mesoderm and cardiomyocyte commitment and diverted cells to an ectoderm-like fate. Mechanistically, ERVH48-1 is localized to sub-cellular membrane compartments through a functional N-terminal signal peptide and binds to the WNT antagonist SFRP2 to promote its polyubiquitination and degradation, thus limiting SFRP2 secretion and blocking repression of WNT/β-catenin signaling. Knockdown of SFRP2 or expression of a chimeric SFRP2 with the ERVH48-1 signal peptide rescued cardiomyocyte differentiation. This study demonstrates how ERVH48-1 modulates WNT/β-catenin signaling and cell type commitment in somatic development.
What problem does this paper attempt to address?